GLENMARK PHARMACEUTICALS LIMITED Environmental Analytics
Environmental and financial analysis dashboard for GLENMARK PHARMACEUTICALS LIMITED. Industry: MANUFACTURING
Company Overview for GLENMARK PHARMACEUTICALS LIMITED
Highlights
Showing data for FY2023
Operational Environmental Cost
$20m
Operational Environmental Cost Intensity
1.41%
Total Environmental Cost
$60m
Total Environmental Cost Intensity
4.26%
ΔOperational Environmental Cost (2020-2023)
$4.92m
Decoupling Rate (2020-2023)
-12%
Adjusted EBITDA
N/A
Adjusted EBITDA Margin
N/A
Environmental cost statement
Showing data for FY2023
| USD MM | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| OPERATIONAL SOCIAL COST OF CARBON | ||||
| 24.12% | -3.02% | 20.88% | ||
| 0.17% | 0.19% | 0.19% | 0.25% | |
| 8.26% | 5.64% | 13.68% | ||
| 0.84% | 0.84% | 0.91% | 1.16% | |
| $15m | $17m | $17m | $20m | |
| 10.85% | 4.05% | 14.91% | ||
| 1.01% | 1.03% | 1.10% | 1.41% | |
| INDIRECT SOCIAL COST OF CARBON | ||||
| -27.02% | 59.46% | 3.35% | ||
| 2.24% | 1.51% | 2.47% | 2.85% | |
| -15.26% | 36.95% | 6.92% | ||
| 3.25% | 2.54% | 3.57% | 4.26% | |
All figures are denominated in millions of USD. USD is the base currency used to monetize, other currency equivalents are calculated using end of year exchange rates. Scope 2: Social Cost of Carbon is calculated using market-based emissions data. | ||||
Environmental cost bridge
Showing data for FY2023
Integrated financial analysis
Highlights
Showing data for FY2023
Adjusted EBITDA Margin
N/A
Adjusted EBIT Margin
N/A
EV / Adjusted EBITDA
Company Value: Placeholder
Industry Average: Placeholder
Coming soon
EV / Adjusted EBIT
Company Value: Placeholder
Industry Average: Placeholder
Coming soon
Integrated income statement
Showing data for FY2023
| USD MM | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| INCOME STATEMENT | ||||
$1,497m | $1,624m | $1,581m | $1,416m | |
| 8.49% | -2.66% | -10.39% | ||
N/A | N/A | N/A | N/A | |
| 0.00% | 0.00% | 0.00% | 0.00% | |
N/A | N/A | N/A | N/A | |
| 0.00% | 0.00% | 0.00% | 0.00% | |
N/A | N/A | N/A | N/A | |
| 0.00% | 0.00% | 0.00% | 0.00% | |
| ENVIRONMENTAL COST DATA | ||||
$15m | $17m | $17m | $20m | |
| 1.01% | 1.03% | 1.10% | 1.41% | |
| FINANCIAL DATA ADJUSTED FOR OPERATIONAL ENVIRONMENTAL COST | ||||
N/A | N/A | N/A | N/A | |
| 0.00% | 0.00% | 0.00% | 0.00% | |
N/A | N/A | N/A | N/A | |
| 0.00% | 0.00% | 0.00% | 0.00% | |
All figures are denominated in millions of USD. USD is the base currency used to monetize, other currency equivalents are calculated using end of year exchange rates. | ||||
Environmental EBITDA bridge
Showing data for FY2023
Industry benchmark
MANUFACTURE OF PHARMACEUTICAL PREPARATIONS
Scope 1 (% of Sales)
0.25%
Scope 2 (% of Sales)
1.16%
Operational Environmental Cost Intensity
1.41%
Scope 3 (% of Sales)
2.85%
Total Environmental Cost Intensity
4.26%
Selected peer group
Showing data for FY2023
NAME | COUNTRY | OPERATIONAL ENV. COST | OPERATIONAL ENV. COST INTENSITY |
|---|---|---|---|
GLENMARK PHARMACEUTICALS LIMITED | IN | $20m | 1.41% |
Loading similar companies data...
Industry distribution
Showing data for FY2023
Note: Outliers are calculated using the 1.5 * IQR method, where values outside Q1 - 1.5 * IQR and Q3 + 1.5 * IQR are considered outliers.
Estimated Social Cost of Carbon Scope 3 breakdown
Percentage breakdown of Social Cost of Carbon Scope 3 into various categories
Showing data for FY2023
SCOPE 3 CATEGORY | Company (USD) | Company % | Industry Avg (USD) | Industry Avg % |
|---|---|---|---|---|
Purchased goods (1 & 2) | $39m | 49.18% | N/A | N/A |
Energy-related activities (3) | $7m | 9.28% | N/A | N/A |
Upstream transportation (4) | $9m | 11.40% | N/A | N/A |
Waste (5) | $1m | 1.11% | N/A | N/A |
Business travel (6) | $1m | 0.69% | N/A | N/A |
Commuting (7) | $1m | 0.68% | N/A | N/A |
Upstream leased assets (8) | N/A | N/A | N/A | N/A |
Downstream transportation (9) | $7m | 8.58% | N/A | N/A |
Processing of products (10) | $0m | 0.03% | N/A | N/A |
Use of products (11) | N/A | N/A | N/A | N/A |
Final treatment of products (12) | $15m | 19.04% | N/A | N/A |
Downstream leased assets (13) | N/A | N/A | N/A | N/A |
Franchises (14) | N/A | N/A | N/A | N/A |
Investments (15) | N/A | N/A | N/A | N/A |
Total | $79m | 100.00% | $0m | 100.00% |
Scope 3 breakdown visualization
Showing data for FY2023